Pancreatic Cancer Research

ResearcherRoswell Park Comprehensive Cancer CenterNo recent work listed

Jianliang Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5370-8446; OpenAlex author ID A5101583160. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2013: 2 papers · 2014: 1 paper · 2015: none · 2016: 1 paper

Papers 4

  1. Genomic Testing for Gemcitabine-Based Treatment of Pancreatic Cancer. Co-author DOI 10.1093/jnci/djv424↗
  2. A small molecule FAK kinase inhibitor, GSK2256098, inhibits growth and survival of pancreatic ductal adenocarcinoma cells. Co-author DOI 10.4161/15384101.2014.949550↗
  3. Plasma adiponectin: a possible link between fat metabolism and pancreatic cancer risk. Co-author DOI 10.1093/jnci/djs522↗
  4. Inhibiting the interaction of cMET and IGF-1R with FAK effectively reduces growth of pancreatic cancer cells in vitro and in vivo. Co-author DOI 10.2174/1871520611313040009↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Steven N. Hochwald · 4 shared papers, 2013–2016 · strength 0.30
  2. Elena Kurenova · 1 shared paper, 2013 · strength 0.04
  3. Deniz A. Uçar · 1 shared paper, 2013 · strength 0.04
  4. Saı̈d M. Sebti · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.